Acquires crude oil and natural gas properties. Explores for crude oil and natural gas reserves. Now — the numbers.
The company is still in the product-building phase: its spending runs above its sales. That only changes once the product starts selling at scale.
Before the clock runs out, either sales must climb sharply or new money must come in. This is the most critical line in the whole picture.
This company is not turning a profit, so the market is pricing its sales instead: 1.8× for every dollar of annual revenue.
Against companies in its own sector, it looks cheaper than 12% of them.
Analysts' average target sits 16% above today's price.
Executives buying with their own money is usually read as confidence in the company’s future.
We compared this company with its own sector across five subjects.
A score of 50 means class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly below the class average.
Clearly above the class average — a step short of the very top.
Valuation: The stock trades at a price that looks expensive next to its earnings; that can cap future returns.
Business Quality: Profit power and business quality trail similar companies in the sector.
The stock trades 27% below its peak. The market has trimmed its expectations for the company.
Sales run at $359.3M a year. A small number, but proof the product has real buyers.
Over the last 12 months, company executives reported 31 buys and 28 sells. Management buying with its own money is usually read as a good sign.
It pays out $0.25 per share each year — regular cash for whoever holds the stock.
A loss of $41.4M against $359.3M in annual sales. And on top of that, sales fell from the year before.
At the current pace of spending, the cash lasts about 1.4 years. After that, the company needs to find new money.
On our five-subject report card, EGY sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: EGY is a high-risk stock — not yet profitable, and its future rides on its product catching on.
Analysts’ average target sits above today’s price, yet the valuation grade (12/100) says the stock isn’t cheap.
Not covered, because the filings we hold do not carry it: the revenue breakdown.